For how we live.
On today's ballot: a measure letting California borrow $8.4 billion for immunology and immunotherapy research, half for a University of California-affiliated institute and half for competitive grants.
A draft NIH policy out for comment would require researchers to share plain-language summary results with clinical research participants for all NIH-supported studies, unless justifiably not appropriate.
The phrase is used loosely and argued about fiercely. At its core is a genuine dilemma: experiments that make a pathogen more dangerous can also be the ones that warn us fastest.
A Federal Register notice opens a five-day comment window in September. The stated goal is to realign clinical operations across the institute and align with Presidential priorities.
Two notices, one day apart, end one line of federally funded research and freeze another pending review. NIH is now asking scientists which experiments could not be done without embryonic stem cells.